Article contents

Articles

The Chronic Myeloid Leukemia In A Black African Drepanocytic Subject: About A Case In The Clinical Hematology Department Of The Donka Hospital And University Center/Conakry.

Authors

  • KANTE Ansoumane Sayon Assistant Chef de clinique à l’Université Gamal Abdel Nasser de Conakry, Service d’hématologie CHU de Donka, Conakry (Rep de Guinée) West Africa.
  • DIAKITE Mamady Assistant Chef de clinique à l’Université Gamal Abdel Nasser de Conakry, Service d’hématologie CHU de Donka, Conakry (Rep de Guinée) West Africa.
  • SYLLA Djibril Maitre-assistant à l’Université Gamal Abdel Nasser de Conakry, Service des urgences CHU de Donka, Conakry (Rep de Guinée) West Africa.
  • KOUAKOU Boidy Enseignant à l’UFR des Sciences médicales l’université Felix Houphouët Boigny d’Abidjan, Service d’hématologie clinique du CHU de Yopougon (Rep de Côte d’Ivoire), West Africa.
  • DAMBAKATE Alassane Assistant Chef de clinique à l’Université Gamal Abdel Nasser de Conakry, Service d’hématologie CHU de Donka, Conakry (Rep de Guinée) West Africa.
  • CAMARA Djongbe Assistant Chef de clinique à l’Université Gamal Abdel Nasser de Conakry, Service d’hématologie CHU de Donka, Conakry (Rep de Guinée) West Africa.
  • KEITA Sadio Assistant Chef de clinique à l’Université Gamal Abdel Nasser de Conakry, Service d’hématologie CHU de Donka, Conakry (Rep de Guinée) West Africa.
  • TOLO Aissata Enseignant à l’UFR des Sciences médicales l’université Felix Houphouët Boigny d’Abidjan, Service d’hématologie clinique du CHU de Yopougon (Rep de Côte d’Ivoire), West Africa.

Abstract

Sickle cell disease is a chronic congenital hemoglobinopathy with some major forms having high morbidity and mortality. The occurrence of chronic myeloid leukemia type malignant hematopathy in this area is rare but not excluded.

This association has drawn our attention to its clinical impact and the challenges of organizing care.

To this end, we report a case of chronic myeloid leukaemia on homozygous SSFA2 major sickle cell disease, diagnosed in a 35-year-old patient. He was treated with Imatinib Mesylate for CML and transfusional exchanges for sickle cell disease. Despite a toxicity noted at the beginning of treatment, the overall evolution thereafter was good with normalization of the blood count and stabilization of the clinical condition.

Article information

Journal

International Journal of Medical Science and Clinical Invention

Volume (Issue)

6 (1)

Pages

4244-4246

Published

2019-01-30

How to Cite

The Chronic Myeloid Leukemia In A Black African Drepanocytic Subject: About A Case In The Clinical Hematology Department Of The Donka Hospital And University Center/Conakry. (2019). International Journal of Medical Science and Clinical Invention, 6(1), 4244-4246. https://doi.org/10.18535/ijmsci/v6i1.01

Downloads

Views

335

Downloads

279